Doctors and Drug Companies: Still Cozy after All These Years

1. BlumenthalD

2004 Doctors and drug companies. N Engl J Med 351 1885 1890

2. HarrisG

SingerN

13 August 2010 U.S. inquiry of drug makers is widened. New York Times. Available: http://www.nytimes.com/2010/08/14/health/policy/14drug.html?scp=3&sq=doctorsdrugcompanies&st=nyt. Accessed 27 September 2010

3. RothmanDJ

McDonaldWJ

BerkowitzCD

ChimonasSC

DeAngelisCD

2009 Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA 301 1367 1372

4. BrennanTA

RothmanDJ

BlankL

BlumenthalD

ChimonasSC

2006 Health industry practices that create conflicts of interest. A policy proposal for academic medical centers. JAMA 295 429 433

5. 2009 S.301–Physician Payments Sunshine Act of 2009 (Introduced in Senate - IS). 111th Congress, 1st session. Washington (D.C.): Library of Congress. Available: http://thomas.loc.gov/cgi-bin/query/z?c111:S.301.IS. Accessed 27 September 2010

6. RobertsonJ

MoynihanR

WalkomE

BeroL

HenryD

2009 Mandatory disclosure of pharmaceutical industry-funded events for health professionals. PLoS Med 6 e1000128 doi:10.1371/journal.pmed.1000128

7. RossC

19 April 2008 State Senate OKs doctor gift ban. First-in-the-nation law targets drug companies. Boston Herald. Available: http://www.bostonherald.com/business/healthcare/view.bg?articleid=1088148&srvc=home&position=also. Accessed 5 October 2010

8. The Pharmaceutical Research and Manufacturers of America (PhRMA) 2008 Code on interactions with healthcare professionals. Available: http://www.phrma.org/files/attachments/PhRMA%20Marketing%20Code%202008.pdf. Accessed 27 September 2010

9. American Medical Association 2010 8.061–Gifts to physicians from industry. In: American Medical Association code of medical ethics. Available: http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics.shtml. Accessed 27 September 2010

10. MoynihanR

2003 Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement. BMJ 326 1193 1195

11. HenryD

DoranE

KerridgeI

HillS

McNeillPM

2005 Ties that bind. multiple relationships between clinical researchers and the pharmaceutical industry. Arch Intern Med 165 2493 2496

12. SpurlingGK

MansfieldPR

MontgomeryBD

LexchinJ

DoustJ

2010 Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med 7 e1000352 doi:10.1371/journal.pmed.1000352

13. EasterbrookPJ

BerlinJA

GopalanR

MatthewsDR

1991 Publication bias in clinical research. Lancet 337 867 872

14. ChanA-W

AltmanDG

2005 Identifying outcome reporting bias in randomized trials on PubMed: review of publications and survey of authors. BMJ 330 753 759

15. National Prescribing Service, Australia 2010 National Prescribing Service home page. Available: http://www.nps.org.au/. Accessed 27 September 2010

16. National Prescribing Centre, United Kingdom 2010 National Prescribing Centre home page. Available: http://www.npc.co.uk/. Accessed 27 September 2010